These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 6309883)
1. Cushing's syndrome secondary to ectopic cortisol production by an ovarian carcinoma. Marieb NJ; Spangler S; Kashgarian M; Heimann A; Schwartz ML; Schwartz PE J Clin Endocrinol Metab; 1983 Oct; 57(4):737-40. PubMed ID: 6309883 [TBL] [Abstract][Full Text] [Related]
2. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398 [TBL] [Abstract][Full Text] [Related]
3. Lysine vasopressin stimulation of cortisol secretion in patients with adrenocorticotropin-independent macronodular adrenal hyperplasia. Horiba N; Suda T; Aiba M; Naruse M; Nomura K; Imamura M; Demura H J Clin Endocrinol Metab; 1995 Aug; 80(8):2336-41. PubMed ID: 7629226 [TBL] [Abstract][Full Text] [Related]
4. Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing's syndrome. Lacroix A; Bolté E; Tremblay J; Dupré J; Poitras P; Fournier H; Garon J; Garrel D; Bayard F; Taillefer R N Engl J Med; 1992 Oct; 327(14):974-80. PubMed ID: 1325608 [TBL] [Abstract][Full Text] [Related]
6. Cushing's syndrome due to an ACTH-producing primary ovarian carcinoma. Al Ojaimi EH Hormones (Athens); 2014; 13(1):140-5. PubMed ID: 24722135 [TBL] [Abstract][Full Text] [Related]
7. Effect of o,p'-DDD on cortisol metabolism in Cushing's syndrome of various etiology. Koide Y; Inoue S; Murayama H; Kawai K; Yamashita K Endocrinol Jpn; 1985 Oct; 32(5):615-24. PubMed ID: 3004927 [TBL] [Abstract][Full Text] [Related]
8. Use of ketoconazole in the treatment of Cushing's syndrome. Loli P; Berselli ME; Tagliaferri M J Clin Endocrinol Metab; 1986 Dec; 63(6):1365-71. PubMed ID: 3023421 [TBL] [Abstract][Full Text] [Related]
9. Cushing's syndrome due to adrenal adenoma with persistent diurnal cortisol secretory rhythm. Olsen NJ; Fang VS; DeGroot LJ Metabolism; 1978 Jun; 27(6):695-700. PubMed ID: 206799 [TBL] [Abstract][Full Text] [Related]
10. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome. Chrousos GP; Schulte HM; Oldfield EH; Gold PW; Cutler GB; Loriaux DL N Engl J Med; 1984 Mar; 310(10):622-6. PubMed ID: 6319991 [TBL] [Abstract][Full Text] [Related]
11. An unusual profile of endocrine study in a patient with pre-Cushing's syndrome. Kodama C; Nakada T; Sasagawa I; Ishigooka M; Yamaguchi T; Suzuki H Int Urol Nephrol; 1993; 25(6):517-24. PubMed ID: 8175270 [TBL] [Abstract][Full Text] [Related]
12. Different sensitivity to adrenocorticotropin of dispersed adrenocortical cells from patients with Cushing's disease with macronodular and diffuse adrenal hyperplasia. Lamberts SW; Bons EG; Bruining HA J Clin Endocrinol Metab; 1984 Jun; 58(6):1106-10. PubMed ID: 6327752 [TBL] [Abstract][Full Text] [Related]
13. Twelve-hour cycles of adrenocorticotropin and cortisol secretion in Cushing's disease. Schteingart DE; McKenzie AK J Clin Endocrinol Metab; 1980 Nov; 51(5):1195-8. PubMed ID: 6252234 [TBL] [Abstract][Full Text] [Related]
14. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome. Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314 [TBL] [Abstract][Full Text] [Related]
15. Ectopic ACTH syndrome associated with ovarian steroid-cell tumor. Sworczak K; Blaut K; Malecha M; Lewczuk A J Endocrinol Invest; 2002 Apr; 25(4):369-72. PubMed ID: 12030610 [TBL] [Abstract][Full Text] [Related]
16. [Investigation of Cushing's syndrome. The diagnostic value of the dexamethasone suppression test, the metopirone test and the CRF test]. Johannesen O; Jørgensen H; Frey H; Norman N Tidsskr Nor Laegeforen; 1989 Sep; 109(26):2678-82. PubMed ID: 2554527 [TBL] [Abstract][Full Text] [Related]
17. Characterization of adrenal autonomy in Cushing's syndrome: a comparison between in vivo and in vitro responsiveness of the adrenal gland. Lamberts SW; Zuiderwijk J; Uitterlinden P; Blijd JJ; Bruining HA; de Jong FH J Clin Endocrinol Metab; 1990 Jan; 70(1):192-9. PubMed ID: 2152930 [TBL] [Abstract][Full Text] [Related]
18. Cushing's syndrome due to unilateral adrenal nodular hyperplasia with incomplete inhibition of the contralateral gland. Catania A; Reschini E; Orsatti A; Motta P; Airaghi L; Cantalamessa L Horm Res; 1986; 23(1):9-15. PubMed ID: 3000913 [TBL] [Abstract][Full Text] [Related]
19. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome. Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900 [TBL] [Abstract][Full Text] [Related]
20. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Addison's disease and Cushing's syndrome: basal concentrations. Peterson ME; Orth DN; Halmi NS; Zielinski AC; Davis DR; Chavez FT; Drucker WD Endocrinology; 1986 Aug; 119(2):720-30. PubMed ID: 3015556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]